Inflation Reduction Act: Implications for US Healthcare and Pharmaceutical Industries
On August 16th, 2022, President Biden signed the Inflation Reduction Act into law, which will bring reforms to Medicare spending and coverage, impacting manufacturers’ long-term P&MA strategy and payer decision-making.